Answers are grounded in this paper and cite their sources.
Intravesical capsaicin shows potential for bladder disorders, highlighting varied patient responses to treatment.
Intravesical capsaicin has been used as a treatment for detrusor overactivity and bladder pain syndromes due to its desensitizing effect on C-fiber afferents. However, patient responses vary widely in both efficacy and tolerability. As a therapeutic option, intravesical capsaicin has largely been replaced by botulinum toxin. However, the drug may still be considered in select cases of refractory disease or within the context of research protocols.
No takes yet. Share an insight, caveat, or question.
Karl‐Erik Andersson (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: